Anti-metastatic functions of type 1 interferons: Foundation for the adjuvant therapy of cancer
Abstract
No abstract availableKeywords
Funding Information
- NIH/NCI (CA165997, CA092900)
This publication has 105 references indexed in Scilit:
- The Vascular Endothelium and Human DiseasesInternational Journal of Biological Sciences, 2013
- Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapiesProceedings of the National Academy of Sciences, 2012
- Tyrosine Phosphorylation of Protein Kinase D2 Mediates Ligand-inducible Elimination of the Type 1 Interferon ReceptorJournal of Biological Chemistry, 2011
- Metastatic Progression of Prostate Cancer and E-CadherinThe American Journal of Pathology, 2011
- Inflammatory signaling compromises cell responses to interferon alphaOncogene, 2011
- Role of p38 Protein Kinase in the Ligand-independent Ubiquitination and Down-regulation of the IFNAR1 Chain of Type I Interferon ReceptorJournal of Biological Chemistry, 2011
- Inducible Priming Phosphorylation Promotes Ligand-independent Degradation of the IFNAR1 Chain of Type I Interferon ReceptorJournal of Biological Chemistry, 2010
- Morbidity and Mortality in Patients with Cancer who Become Nonambulatory after Spinal Cord Compression: A Case Series on End-of-Life CareJournal of Palliative Medicine, 2009
- IFNα activates dormant haematopoietic stem cells in vivoNature, 2009
- Inactivation of the E-Cadherin-Mediated Cell Adhesion System in Human CancersThe American Journal of Pathology, 1998